• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病及其他B细胞恶性肿瘤中的BCL3重排和t(14;19):一项分子与细胞遗传学研究

BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.

作者信息

McKeithan T W, Takimoto G S, Ohno H, Bjorling V S, Morgan R, Hecht B K, Dubé I, Sandberg A A, Rowley J D

机构信息

Department of Pathology, University of Chicago, IL 60637, USA.

出版信息

Genes Chromosomes Cancer. 1997 Sep;20(1):64-72.

PMID:9290956
Abstract

The t(14;19)(q32.3;q13.1) is a recurring translocation found in the neoplastic cells of some patients with chronic lymphocytic leukemia (CLL) or other B-lymphocytic neoplasms. We previously cloned the translocation breakpoint junctions present in the leukemic cells from three such patients and identified a gene, BCL3, whose transcription is increased as a result of the translocation. In the present paper, we describe three additional patients with the t(14;19), one with lymphoma and two with CLL, and report the cloning and sequencing of the breakpoint junction in one of these patients as well as in a previously reported patient. We and others have found that the breakpoints on chromosome 14, with one exception, fall within the switch region upstream of the immunoglobulin heavy chain C alpha 1 or C alpha 2 sequences. Several of the breaks within chromosome 19 fall immediately upstream of the BCL3 gene, but several others are more than 16 kb 5' of the gene. Most patients with CLL and the t(14;19) also show trisomy 12.

摘要

t(14;19)(q32.3;q13.1)是在一些慢性淋巴细胞白血病(CLL)患者或其他B淋巴细胞肿瘤患者的肿瘤细胞中发现的一种反复出现的易位。我们之前克隆了来自三名此类患者白血病细胞中的易位断点连接,并鉴定出一个基因BCL3,其转录因易位而增加。在本文中,我们描述了另外三名患有t(14;19)的患者,一名患有淋巴瘤,两名患有CLL,并报告了其中一名患者以及一名先前报道患者的断点连接的克隆和测序情况。我们和其他人发现,14号染色体上的断点,除了一个例外,都落在免疫球蛋白重链Cα1或Cα2序列上游的转换区域内。19号染色体上的几个断点紧邻BCL3基因上游,但其他几个断点在该基因5'端上游超过16 kb处。大多数患有CLL和t(14;19)的患者也显示12号染色体三体。

相似文献

1
BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study.慢性淋巴细胞白血病及其他B细胞恶性肿瘤中的BCL3重排和t(14;19):一项分子与细胞遗传学研究
Genes Chromosomes Cancer. 1997 Sep;20(1):64-72.
2
Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia.慢性淋巴细胞白血病中t(14;19)(q32;q13)易位的分子特征分析
Leukemia. 1993 Dec;7(12):2057-63.
3
Involvement of the BCL3 gene in two patients with chronic lymphocytic leukemia.BCL3基因在两名慢性淋巴细胞白血病患者中的作用。
Int J Hematol. 1994 Apr;59(3):211-8.
4
BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders.淋巴增生性疾病中的BCL3重排与t(14;19)(q32;q13)
Genes Chromosomes Cancer. 1996 Jan;15(1):38-47. doi: 10.1002/(SICI)1098-2264(199601)15:1<38::AID-GCC6>3.0.CO;2-5.
5
The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases.t(14;19)(q32;q13)阳性小B细胞白血病:7例临床病理及细胞遗传学研究
Br J Haematol. 2007 Jan;136(2):220-8. doi: 10.1111/j.1365-2141.2006.06416.x. Epub 2006 Nov 27.
6
Cytogenetic 2; 18 and 18; 22 translocation in chronic lymphocytic leukemia with juxtaposition of bcl-2 and immunoglobulin light chain genes.慢性淋巴细胞白血病中2号与18号、18号与22号染色体易位,伴bcl-2与免疫球蛋白轻链基因并置
Oncogene. 1992 Mar;7(3):573-7.
7
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.携带BCL1易位的非典型慢性淋巴细胞白血病的细胞遗传学和间期细胞遗传学特征
Cancer Res. 1997 Mar 15;57(6):1144-50.
8
Splenic small B-cell lymphoma with IGH/BCL3 translocation.伴有IGH/BCL3易位的脾脏小B细胞淋巴瘤
Hum Pathol. 2006 Feb;37(2):218-30. doi: 10.1016/j.humpath.2005.09.025.
9
[Isolation of a novel candidate proto-oncogene involved in human lymphoid neoplasm].[一种参与人类淋巴样肿瘤的新型候选原癌基因的分离]
Rinsho Ketsueki. 1991 Jun;32(6):655-9.
10
Molecular cloning and characterization of the t(2;14) translocation associated with childhood chronic lymphocytic leukemia.与儿童慢性淋巴细胞白血病相关的t(2;14)易位的分子克隆与特征分析
Oncogene. 1992 May;7(5):961-70.

引用本文的文献

1
IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance.IFNγ诱导的卵巢癌中Bcl3、PD-L1和IL-8信号传导:机制与临床意义
Cancers (Basel). 2024 Jul 27;16(15):2676. doi: 10.3390/cancers16152676.
2
Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.通过 G 带和荧光原位杂交鉴定与 t(14;19)(q32;q13)/IGH::BCL3 相关的不同 B 细胞肿瘤。
J Clin Exp Hematop. 2024;64(1):21-31. doi: 10.3960/jslrt.23053.
3
Incorporating network diffusion and peak location information for better single-cell ATAC-seq data analysis.
融合网络扩散和峰位置信息以改善单细胞 ATAC-seq 数据分析。
Brief Bioinform. 2024 Jan 22;25(2). doi: 10.1093/bib/bbae093.
4
Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age.BCL3 在癌症中的多效性作用:原癌基因的成熟。
Mol Cancer. 2024 Jan 9;23(1):7. doi: 10.1186/s12943-023-01922-8.
5
[Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].20例伴t(14;19)(q32;q13)的小B淋巴细胞增殖性疾病临床分析
Zhonghua Xue Ye Xue Za Zhi. 2022 Aug 14;43(8):674-679. doi: 10.3760/cma.j.issn.0253-2727.2022.08.010.
6
miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance.淋巴细胞白血病中的 miRNAs-耐药的 miRror。
Int J Mol Sci. 2022 Apr 22;23(9):4657. doi: 10.3390/ijms23094657.
7
Bcl-3: A Double-Edged Sword in Immune Cells and Inflammation.Bcl-3:免疫细胞和炎症中的双刃剑。
Front Immunol. 2022 Mar 10;13:847699. doi: 10.3389/fimmu.2022.847699. eCollection 2022.
8
Case Report: Chronic Lymphocytic Leukemia With a Rare Translocation t(14;19)(q32;q13) Involving IGH Rearrangements: Report of Three Chinese Cases and Literature Review.病例报告:伴有罕见的涉及IGH重排的t(14;19)(q32;q13)易位的慢性淋巴细胞白血病:三例中国病例报告及文献综述
Front Oncol. 2020 Nov 19;10:594732. doi: 10.3389/fonc.2020.594732. eCollection 2020.
9
The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells.原癌基因 Bcl3 诱导免疫检查点 PD-L1 表达,介导卵巢癌细胞的增殖。
J Biol Chem. 2018 Oct 5;293(40):15483-15496. doi: 10.1074/jbc.RA118.004084. Epub 2018 Aug 22.
10
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.淋巴恶性肿瘤中的核因子-κB激活:遗传学、信号传导与靶向治疗
Biomedicines. 2018 Mar 26;6(2):38. doi: 10.3390/biomedicines6020038.